Evidence map›Paper›PMID 34773126›Full record

ArticleArchives of toxicology2022

Investigations on detoxification mechanisms of novel para-phenylenediamine analogues through N-acetyltransferase 1 (NAT-1).

Gopalakrishnan Venkatesan, Zhi Chiaw Lim, Aneesh V Karkhanis, Yub Raj Neupane, Yuri Dancik, Chenyuan Huang, Paul Bigliardi, Giorgia Pastorin

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Gopalakrishnan VenkatesanAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, 1 CREATE Way, #12-02 CREATE Tower, Singapore, 138602, Singapore. gopal.venkatesan@smart.mit.edu.ORCID 0000-0002-9520-473X
Zhi Chiaw LimDepartment of Chemistry, National University of Singapore, Lower Kent Ridge Road, 4 Science Drive 3, Singapore, 117544, Singapore.
Aneesh V KarkhanisSkin Research Institute of Singapore, A*STAR, 8A Biomedical Grove, Immunos Building, Singapore, 138665, Singapore.
Yub Raj NeupaneDepartment of Pharmacy, National University of Singapore, Lower Kent Ridge Road, 4 Science Drive 2, Singapore, 117544, Singapore.
Yuri DancikLe Studium Loire Valley Institute of Advanced Studies, Orléans, France.
Chenyuan HuangNUS Yong Loo Lin School of Medicine, 1E Kent Ridge Road, Singapore, 119228, Singapore.
Paul BigliardiDivision of Dermato-Allergy, Department of Dermatology, University of Minnesota, 420 Delaware St SE, Minneapolis, MN, 55455, USA.
Giorgia PastorinDepartment of Pharmacy, National University of Singapore, Lower Kent Ridge Road, 4 Science Drive 2, Singapore, 117544, Singapore. phapg@nus.edu.sg.ORCID 0000-0002-2568-0626
National University of Singapore · SGAgency for Science, Technology and Research · SGUniversité de Tours · FRUniversity of Minnesota · US

Funding

Biomedical Data Translator Technical Feasibility Assessment and Architecture DesignOT3TR002020 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AHALT, STANLEY CARLTON, TROPSHA, ALEXANDER · 2016 to 2019
$3.1M
Society for Epidemiologic Research Doctoral Dissertation WorkshopR13TR002021 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HARLOW, BERNARD L · 2017 to 2018
$46k
ministry of education singapore R-148-000-284-114ministry of education singapore R--148-000-296-114nanomedicine translational research program (nuhsro/2021/034/trp/09/nanomedicine) and nuhsro/2020/002/nanonash/loa HSRO/2021/034/TRP/09/Nanomedicinenanomedicine translational research program (nuhsro/2021/034/trp/09/nanomedicine) and nuhsro/2020/002/nanonash/loa NUHSRO/2020/002/NanoNash/LOAnus technology acceleration programme (tap), project id tap2002019-04-13 TAP2002019-04-13
6 · The paper itself

Abstract

Para-phenylenediamine (PPD) is one of the most used chemicals in oxidative hair dyes. However, its use has been associated with adverse effects on health, including contact dermatitis and other systemic toxicities. Novel PPD derivatives have been proposed as a safer replacement for PPD. This can be achieved if these molecules minimally permeate the skin and/or are easily metabolised by enzymes in the skin (e.g., N-acetyltransferase-1 (NAT-1)) into innocuous compounds before gaining systemic entry. This study investigated the detoxification pathway mediated by NAT-1 enzymes on 6 synthesized PPD analogues (namely, P1-P6) with different chemical properties, to study the role of functional groups on detoxification mechanisms in HaCaT skin cells. These compounds were carefully designed with different chemical properties (whereby the ortho position of PPD was substituted by nucleophile and electrophile groups to promote N-acetylation reactions, metabolism and clearance). Compounds P2-P4 N-acetylated at 54-49 nmol/mg/min, which is 1.6 times higher than N-acetylation of PPD, upregulated NAT-1 activity from 8-7% at 50 μM to 22-11% at 100 μM and showed 4 times higher rate of elimination (k equal to 0.141 ± 0.016-0.124 ± 0.01 h

Indexed as

Dermatitis, Allergic ContactHair DyesArylamine N-AcetyltransferaseHumansIsoenzymesPhenylenediamines4-phenylenediamineArylamine N-AcetyltransferaseHair DyesIsoenzymesN-acetyltransferase 1PhenylenediaminesHaCaT: human keratinocytes cellsLC–MS/MSMetabolismN-acetyl transferase-1Para-phenylenediamineTandem Mass spectrometry

Identifiers

PMID34773126
OpenAlexW3213860246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.